Annual Drug Patent Expirations for DEFINITY
Definity is a drug marketed by Lantheus Medcl and is included in one NDA. It is available from one supplier. There are eight patents protecting this drug.
This drug has sixty-six patent family members in seventeen countries.
The generic ingredient in DEFINITY is perflutren. One supplier is listed for this compound. Additional details are available on the perflutren profile page.
For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com
